Loading...
Alzamend Neuro Inc (ALZN) is not a strong buy at this time for a beginner, long-term investor with $50,000-$100,000 to invest. The stock exhibits bearish technical indicators, lacks positive news or catalysts, and shows weak financial performance. Given the absence of Intellectia Proprietary Trading Signals and no significant trading trends, it is best to hold off on investing in this stock for now.
The stock is in a bearish trend with MACD below 0 and negatively expanding, RSI indicating oversold conditions at 18.213, and bearish moving averages (SMA_200 > SMA_20 > SMA_5). Key support levels are at 1.677 and 1.523, with resistance at 1.926 and 2.176.
NULL identified. No recent news or significant trading trends from hedge funds or insiders.
Bearish technical indicators, weak financial performance with significant YoY declines in EPS (-91.69%) and net income (-29.29%), and no valuation data available.
In Q2 2026, the company reported no revenue growth (0% YoY), a net income drop to -1,000,758 (-29.29% YoY), and a significant EPS decline to -0.3 (-91.69% YoY). Gross margin remains at 0.
No analyst rating or price target changes available.